NCT06560853

Brief Summary

In Zambia, the health and well-being of children aged 5 to 14 has often been overlooked, leading to various health challenges affecting their development and education. The Healthy Learners (HL) program, in collaboration with the Zambian Government, aims to address this gap by implementing a comprehensive school health program. Trained teachers, known as school health workers (SHWs), play a key role by delivering health education, coordinating preventative care with local clinics, and overseeing a 'school health room' for sick students. This study is a large cluster-randomized control trial in 225 schools. The goal of this trial is to compare the effects of the comprehensive school health programme (SHP) developed by HL against two alternatives: the current level of school health provision and the current school health activities enhanced with deworming and vitamin A coordination by HL, with their technical and financial support ensuring the reliable delivery of all health activities currently planned by the government.

  1. 1.What is the impact of the program on health-seeking, health, and education outcomes?
  2. 2.What are the indirect effects of the program on teachers and clinics?
  3. 3.What is the added value of such a comprehensive SHP, compared to (i) optimized (ii) or imperfect (status-quo) delivery of a limited range of school health activities (e.g., deworming and vitamin A supplements)?
  4. 4.How costly is the comprehensive SHP, and what factors affect its implementation?
  5. 5.What are the potential benefits of the program for long-term human capital accumulation (learning, well-being etc)?

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28,700

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2024Nov 2026

Study Start

First participant enrolled

February 27, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 19, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

August 19, 2024

Status Verified

August 1, 2024

Enrollment Period

2.8 years

First QC Date

August 12, 2024

Last Update Submit

August 15, 2024

Conditions

Keywords

School Health Services

Outcome Measures

Primary Outcomes (2)

  • Synthetic morbidity index

    Because the SHP delivers treatment of several diseases, we will create a composite disease burden index of the following outcomes: * malaria positive (using a rapid diagnostic test) * moderate to high worm load (using a stool test) * anaemia (using a hemocue test) * schistosomiasis (using a urine test) * diarrhoea in the past week (learner self-report) We test these outcomes in a randomly selected panel of 13,300 learners recruited at baseline, which ensures variety of age groups and balance of genders.

    18 months after intervention start

  • Average attendance rate over 24 months

    We will measure attendance during unannounced attendance spot checks (one per term over a 2-year period). Multiple measurements are required to capture seasonal variation. On each spot check visit, we will check attendance of a panel of learners randomly selected at baseline, which ensures variety of age groups and balance of genders. We will calculate each child's attendance rate across all the spot checks.

    24 months after intervention start

Study Arms (3)

School health programme (SHP)

EXPERIMENTAL

SHP developed by Healthy Learners (HL) in collaboration with the Ministry of Education (MOE), which follows the WHO guidelines on school health activities. HL supports the upgrading of basic sanitation facilities and construction of a dedicated 'health room' in the school; trains selected teachers to become school health workers (SHWs) who deliver health and sanitation education, coordinate deworming and vitamin A supplementation in the school, and assess sick learners in the school health room using a clinical decision support system (CDSS), either treating in school or referring to the local health centre. At the health centre, children referred by SHWs are given priority by health care workers who see them within 30 minutes of arriving at the facility. Schools also create student networks (a "buddy" system) whereby learners monitor each other's absence and coordinate with SHWs, who can then follow up with the household.

Other: Comprehensive School Health ProgrammeOther: Deworming and vitamin A supplementation delivery

Deworming and vitamin A supplementation

ACTIVE COMPARATOR

Healthy Learners will enusre reliable delivery of the national deworming programme twice a year, during the same period as in the SHP arm, for comparability of the effect of prevention alone to the full SHP.

Other: Deworming and vitamin A supplementation delivery

Status quo

NO INTERVENTION

Schools to operate as usual with no intervention other than the usual activities planned and organized by the government, as set out the 2006 School Health and Nutrition Policy, until the end of the trial.

Interventions

Combination intervention which consists of: * Upgrading sanitation facilities and constructing a 'health room' in the school * Health teacher training: 5-10 teachers per school are recruited and trained for two weeks to become School Health Workers (SHWs) by Healthy Learners * The SHWs: (1) deliver education on health and good sanitation and hygiene (2) coordinate with local clinics to deliver preventive care (e.g. school deworming and vitamin A supplementation); (3) assess sick students in the health room with a tablet-based clinical decision support system (CDSS); (4) treat sick students in the health room for some conditions (malaria, diarrhoea, schistosomiasis, pneumonia, conjunctivitis) or (5) refer to the health facility for treatment; (6) monitor absence of learners * Referral: learners referred by SHWs are given a referral form by the SHW, which contains information about symptoms and suggested diagnosis by the CDSS. The learners are prioritised in the local clinic.

Also known as: SHP
School health programme (SHP)

Schools implement the government policy of distributing deworming drugs and vitamin A supplementation to learners twice a year. Additional support from Healthy Learners ensures reliable delivery.

Also known as: Deworming
Deworming and vitamin A supplementationSchool health programme (SHP)

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
* Schools: eligible for SHP (not inaccessible in the rainy season, within 10km of health centre) * School administrator: has at least one year experience in school and is the primary or deputy school manager (e.g., headteacher, deputy headteacher, senior teacher acting as financial officer) * Learners: registered and in attendance in school during baseline, in grade 1, grade 3, or grade 5 * Parents, primary caregivers or guardians of selected learners. Guardians are eligible if they stay with the child and make schooling and health decisions for the child in the absence of parents/primary caregivers. * Teachers: any teacher employed by study eligible schools (not volunteers) * Health facilities: designated facilities in the catchment area of study schools * Health facility staff: any staff doing OPD consultation present during facility data collection days

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (6)

Chingola District Education Board

Chingola, Copperbelt, Zambia

Location

Luanshya District Education Board

Luanshya, Copperbelt, Zambia

Location

Masaiti District Education Board

Masaiti, Copperbelt, Zambia

Location

Kawambwa District Education Board

Kawambwa, Luapula Province, Zambia

Location

Mwense District Education Board

Mwense, Luapula Province, Zambia

Location

Samfya District Education Board

Samfya, Luapula Province, Zambia

Location

MeSH Terms

Conditions

Trematode InfectionsMalariaSchistosomiasisAnemiaDiarrheaExanthemaCough

Condition Hierarchy (Ancestors)

HelminthiasisParasitic DiseasesInfectionsProtozoan InfectionsMosquito-Borne DiseasesVector Borne DiseasesHematologic DiseasesHemic and Lymphatic DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsSkin DiseasesSkin and Connective Tissue DiseasesRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, Respiratory

Study Officials

  • Mylene Lagarde, PhD

    London School of Economics and Political Science

    PRINCIPAL INVESTIGATOR
  • David Ross, PhD

    University of Stellenbosch

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Blinding of intervention units, i.e. schools, to their own treatment (or that of others) is not feasible. After the initial scoping and baseline data collection (during which treatment was masked to all participants and assessors), due to the nature of the intervention, there will be no blinding: both the beneficiaries and assessors monitoring the outcomes will be able to infer whether the school is receiving the HL programme or not.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Clusters (schools) are randomised to one of 3 treatment arms. Non-compliance with treatment or control is possible if participants move between schools. We expect low rates of transfers and will track any transfers which do occur.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 19, 2024

Study Start

February 27, 2024

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

August 19, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

The investigators will share a complete dataset at the individual-level containing all primary and secondary study outcomes, any other variables used in the analysis, and treatment assignments. Data will be anonymised to ensure no participants can be personally identified (directly or indirectly)

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data will be available permanently. They will become available along with the publication of the study in a journal, as we will provide a replication package as part of the publication.

Locations